BV
Biotechnology Value Fund L.P. disclosed a 6.1% stake in TYRA
Biotechnology Value Fund L.P. reported owning 6.1% of Tyra Biosciences, Inc. (TYRA) (4,215,886 shares) in a Schedule 13G filed Sep 21, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 21, 2026
- Source
- Schedule 13G